Inhibition of sodium-glucose cotransporter 2 to slow the progression of chronic kidney disease
Abstract
Chronic kidney disease (CKD) is a major public health problem, increasing the risk of cardiovascular events and death and potentially leading to kidney failure. Novel drugs that slow the progression of this non-communicable disease are therefore urgently needed. Initially developed as glucose-lowering drugs, inhibitors of the sodium-glucose cotransporter 2 (SGLT2) drastically reduce the overall mortality and cardiovascular events and slow the...
Paper Details
Title
Inhibition of sodium-glucose cotransporter 2 to slow the progression of chronic kidney disease
Published Date
Aug 17, 2021
Journal
Volume
77
Issue
4
Pages
805 - 814
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History